Metro Healthcare Indonesia Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 90× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 346.3K). Which is the better fit depends on your goals.
| CARE | DKHH | |
|---|---|---|
Market Cap | 14.23T | 158.12B |
Volume | 346.3K | 8.21M |
Lot | 3.46K | 82.15K |
Turnover | 147.93M | 515.2M |
Average Price | 427.18 | 62.72 |
Value | 147.93M | 515.2M |
Indicative Equilibrium Price | 428 | 63 |
Indicative Equilibrium Volume | 10 | 1.33K |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →